Treatment of Hypoglycemia in Infants
For infants with hypoglycemia who are awake and able to swallow, immediately administer oral glucose (preferably 40% dextrose gel) combined with feeding, while infants who are unable to swallow, seizing, or not improving within 10 minutes require emergency activation and intravenous dextrose administration. 1
Initial Assessment and Route Selection
Conscious Infants Who Can Swallow
- Administer oral glucose as the first-line treatment for conscious infants capable of swallowing 1
- Oral glucose (swallowed) is superior to buccal administration and should be the preferred route when the infant cooperates 1
- If the infant is uncooperative with swallowing, sublingual glucose administration using a slurry of granulated sugar and water applied under the tongue is reasonable 1
- Combined oral plus buccal glucose gel (40% dextrose gel) can be used if glucose tablets are not immediately available 1, 2
Specific Glucose Gel Protocol for Neonates
- 40% dextrose gel administered buccally plus feeding (breast milk or formula) is highly effective for neonatal hypoglycemia and supports continued breastfeeding 2, 3
- This approach increases blood glucose by approximately 11.7 mg/dL within 90 minutes, with dextrose gel providing an additional 3.0 mg/dL increase over placebo 2
- Dextrose gel combined with breastfeeding reduces the need for repeat treatment and NICU admissions by up to 73% 2, 3
When to Activate Emergency Services
Immediately activate EMS for any of the following scenarios: 1
- Infant unable to swallow or not awake
- Seizure activity occurs
- Infant does not improve within 10 minutes of oral glucose administration
- Any infant less than 6 months of age with hypoglycemia and altered mental status
Parenteral Treatment for Severe Cases
Indications for IV Dextrose
- Symptomatic hypoglycemia (seizures, coma, severe neurological disturbance) always requires continuous intravenous dextrose infusion 4, 5
- Blood glucose persistently below 1.4 mmol/L (25 mg/dL) mandates parenteral glucose regardless of symptoms 6
- Infants requiring dextrose infusion rates above 12 mg/kg/min need investigation for underlying causes of hypoglycemia 4
Critical Thresholds to Recognize
- Repetitive or prolonged hypoglycemia ≤2.5 mmol/L (45 mg/dL) must be avoided in all infants due to risk of permanent neurological injury 1
- Extremely low glucose (0 to <1.0 mmol/L or <18-20 mg/dL) for more than 1-2 hours with clinical signs indicates high risk for CNS injury 5
- Operational threshold for intervention in at-risk infants is maintaining blood glucose ≥2.6 mmol/L (47 mg/dL) 6
Monitoring and Follow-Up
- Recheck blood glucose 15 minutes after treatment 7
- Expect initial response within 10-20 minutes of oral glucose administration 8, 7
- If hypoglycemia persists after 15 minutes, repeat the glucose dose 7
- Once blood glucose normalizes, provide a feeding to prevent recurrence 9
Critical Pitfalls to Avoid
Never administer oral glucose to infants who are not awake or unable to swallow due to aspiration risk 1
- Do not delay treatment—even brief hypoglycemia can rapidly progress to severe hypoglycemia with seizures 8
- Avoid adding protein or fat to acute treatment, as these do not raise glucose effectively and may delay recovery 7
- Do not use formula alone without glucose supplementation in the acute phase, though formula does provide a greater glucose increase than breast milk alone (additional 3.8 mg/dL) 2
- Blood glucose measurement accuracy is compromised by handheld meters in neonates; blood gas analyzers provide the most accurate results when available 1
Special Considerations for Neonates
- Supervised breastfeeding may be an initial treatment option for asymptomatic hypoglycemia in otherwise healthy term infants 4, 6
- Breastfeeding is associated with reduced need for repeat glucose gel treatment despite not raising glucose as rapidly as formula 2
- Early and exclusive breastfeeding with maintenance of normal body temperature are sufficient preventive measures in healthy term infants 6
- Very few healthy, breastfed term infants have glucose levels <2.0 mmol/L, and values down to 1.7 mmol/L may be acceptable during the first day of life in asymptomatic healthy infants 6
Glucagon Use in Infants
For infants weighing less than 25 kg or younger than 6 years with severe hypoglycemia unresponsive to oral treatment, administer 0.5 mg (0.5 mL) glucagon subcutaneously, intramuscularly, or intravenously 9